Registration
Registration
Registration
A decade on, there’s less revascularization with FFR-guided complete vs culprit only PCI, but COMPLETE-2 is on the way.
Troponin testing is overused in some EDs and underused in others. Cian McCarthy, MB, BCh, explains why this needs to change.
The observed treatment rates, which “absolutely can go higher,” wouldn’t be acceptable for serious cancers, Stephen Greene says.
A decade on, there’s less revascularization with FFR-guided complete vs culprit only PCI, but COMPLETE-2 is on the way.
Current guidelines support culprit-only PCI in these cases, but the “hypothesis-generating” results suggest taking a closer look.